Giagounidis, A., Mufti, G. J., Fenaux, P., Sekeres, M. A., Szer, J., Platzbecker, U., . . . Kantarjian, H. M. (2014). Results of a randomized, double-blind study of romiplostim versus placebo in patients with low/intermediate-1–risk myelodysplastic syndrome and thrombocytopenia. Cancer.
Chicago Style aipamenaGiagounidis, Aristoteles, et al. "Results of a Randomized, Double-blind Study of Romiplostim Versus Placebo in Patients With Low/intermediate-1–risk Myelodysplastic Syndrome and Thrombocytopenia." Cancer 2014.
MLA aipamenaGiagounidis, Aristoteles, et al. "Results of a Randomized, Double-blind Study of Romiplostim Versus Placebo in Patients With Low/intermediate-1–risk Myelodysplastic Syndrome and Thrombocytopenia." Cancer 2014.
Kontuz: berrikusi erreferentzia hauek erabili aurretik.